Jian Xin Chen
Technik-/Wissenschafts-/F&E-Leiter bei BIOMICS BIOPHARMA LTD
Profil
Jian Xin Chen is currently the Chief Technology Officer & Vice President at Biomics Biotechnologies Co., Ltd.
and the Chief Technology Officer at Biomics Biopharma Ltd.
Prior to his current positions, he worked as a Principal at Arbutus Biopharma Corp.
and Alnylam Pharmaceuticals, Inc. Chen received his undergraduate degree from Wuhan University, his doctorate from the University of British Columbia in 1991, and his graduate degree from the Chinese Academy of Sciences in 1984.
Aktive Positionen von Jian Xin Chen
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOMICS BIOPHARMA LTD | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 |
Biomics Biotechnologies Co., Ltd.
 Biomics Biotechnologies Co., Ltd. BiotechnologyHealth Technology Biomics Biotechnologies Co., Ltd. develops ribonucleic acid interference based treatment products. Its products offer treatments for Age-related Macular Degeneration (AMD), Hepatitis B, bladder cancer, and other diseases. The company was founded by York Yuan Zhu on February 17, 2006 and is headquartered in Nantong, China. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 |
Ehemalige bekannte Positionen von Jian Xin Chen
| Unternehmen | Position | Ende |
|---|---|---|
| ARBUTUS BIOPHARMA CORPORATION | Corporate Officer/Principal | - |
| ALNYLAM PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Ausbildung von Jian Xin Chen
| University of British Columbia | Doctorate Degree |
| Chinese Academy of Sciences | Graduate Degree |
| Wuhan University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Health Technology |
| ARBUTUS BIOPHARMA CORPORATION | Health Technology |
| BIOMICS BIOPHARMA LTD | Process Industries |
| Private Unternehmen | 1 |
|---|---|
Biomics Biotechnologies Co., Ltd.
Biomics Biotechnologies Co., Ltd. BiotechnologyHealth Technology Biomics Biotechnologies Co., Ltd. develops ribonucleic acid interference based treatment products. Its products offer treatments for Age-related Macular Degeneration (AMD), Hepatitis B, bladder cancer, and other diseases. The company was founded by York Yuan Zhu on February 17, 2006 and is headquartered in Nantong, China. | Health Technology |
